research-retractions
10 stories tagged "research-retractions"
The Byline Broker Signed Its Sales Pitch With a London Oncologist's Name
Springer Journals Online sold co-author slots on papers it said were nearly through review at Elsevier, Wiley and Springer Nature, and signed the pitch with a cancer researcher's name. Its website is gone. The manuscripts have not been publicly identified.
CancerNature Medicine Retracted the Lung Cancer Trial That Made Infusion Timing Look Like a Free Win
Its protocol was dated January 2022 but cited papers from 2024, and the editors called its survival curve smoother than a phase 3 trial should produce. A top journal published it anyway. The early-infusion claim is gone, but the body-clock question is still open.
InvestigationsPhysics of Fluids Sent a Postdoc's Name to the Authors Whose Algebra He Flagged
AIP Publishing tells its editors to protect the anonymity of anyone raising a concern. Physics of Fluids sent a postdoc's name, institution and rank to the authors he challenged, and 8 referees later found nothing to defend in their paper.
InvestigationsThe Zombie Papers: Retracted Stem-Cell Studies Still Feeding the Unproven-Cure Marketplace
A stem-cell paper retracted in November 2021 kept collecting citations for years, 72 by mid-2026, 27 of them after the notice went up, 15 since 2023 that never mention it. Two researchers counted, and named who is supposed to be cleaning up.
Investigations'No Falsification': JAMA Keeps a Purdue-Funded Opioid Paper Its Own Retraction Rule Says to Pull
Court records from a 2007 federal case show Purdue had flagged 8 possible-withdrawal cases a year before its 2000 study called withdrawal rare. The journal says that isn't falsification, so the paper stays in print.
InvestigationsNEJM Retracted the Study That Approved Amgen's Vasculitis Drug. It Had Never Done That in 200 Years.
The FDA says the drug's superiority result came from re-scoring nine patients after the trial was unblinded. It is still on U.S. shelves while Amgen fights the withdrawal.
InvestigationsRetracted by Its Title: A Vaccine-SIDS Paper and a Standard That Isn't Science
A vaccine-safety paper sat in a peer-reviewed journal for five years, then was pulled in 2026 with a critic saying its title alone disqualified it. The science against the paper is strong; the retraction that followed wasn't science.
InvestigationsA DC judge dismissed the Study 329 suit. The court did not say the paper is honest.
A DC court dismissed an attempt to force JAACAP and Elsevier to retract Study 329. The ruling did not find the paper sound. It found that no reader has standing to make a journal stop selling a fraudulent article.
InvestigationsA Senate hearing finally put the cancer question on the record. The journal notice had been up for months.
Sen. Ron Johnson's June 3 subcommittee hearing on plausible mechanisms linking mRNA injections to cancer, the South Korean cohort behind it, and the editorial notice Springer had posted on the paper months earlier.
InvestigationsVietnam's New Integrity Rule Arrives 251 Retractions Late
Vietnam's Ministry of Science and Technology issued a research-integrity framework with permanent bans on May 25, 2026. The Retraction Watch database already lists 251 retractions carrying Vietnamese affiliations.